BlackDiamond Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$496K Buy
3,785
+233
+7% +$27.3K 0.2% 111
2026
Q1
$427K Sell
3,552
-173
-5% -$20K 0.21% 105
2025
Q4
$438K Buy
3,725
+215
+6% +$20.2K 0.21% 100
2025
Q3
$295K Buy
3,510
+457
+15% +$37.6K 0.16% 120
2025
Q2
$250K Buy
3,053
+76
+3% +$6.04K 0.14% 136
2025
Q1
$226K Sell
2,977
-1,666
-36% -$156K 0.15% 135
2024
Q4
$462K Buy
4,643
+495
+12% +$51K 0.27% 79
2024
Q3
$409K Buy
4,148
+244
+6% +$29K 0.25% 92
2024
Q2
$445K Buy
3,904
+479
+14% +$61.7K 0.29% 80
2024
Q1
$452K Buy
3,425
+73
+2% +$9K 0.32% 78
2023
Q4
$423K Buy
3,352
+452
+16% +$46.9K 0.31% 75
2023
Q3
$298K Buy
2,900
+34
+1% +$3.67K 0.27% 88
2023
Q2
$308K Buy
2,866
+349
+14% +$39.6K 0.26% 87
2023
Q1
$293K Sell
2,517
-147
-6% -$15.9K 0.3% 76
2022
Q4
$295K Buy
2,664
+199
+8% +$20.3K 0.33% 75
2022
Q3
$241K Buy
2,465
+12
+0.5% +$1.07K 0.29% 88
2022
Q2
$220K Buy
+2,453
New +$217K 0.27% 101

Other funds holding MRK

BlackDiamond Wealth Management's MRK Position: Q2 2026 in Review

BlackDiamond Wealth Management increased its Merck (MRK) stake by 6.6% in Q2 2026, buying an estimated $27.3K and bringing the position to 3,785 shares worth $496K. The position accounts for 0.2% of the portfolio, ranked #111.

BlackDiamond Wealth Management first reported a position in MRK in Q2 2022 and has held it in 17 quarters since. 3,845 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • BlackDiamond Wealth Management held 3,785 shares of Merck worth $496K as of Q2 2026.
  • BlackDiamond Wealth Management bought 233 Merck shares in Q2 2026, an estimated $27.3K.
  • Merck made up 0.2% of BlackDiamond Wealth Management's portfolio in Q2 2026, its #111 holding.
  • BlackDiamond Wealth Management first reported a position in Merck in Q2 2022 and has held it in 17 quarters since.
  • 3,845 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on BlackDiamond Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.